Histone acetylation modulation by small molecules: A chemical approach

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1799, Issue 10-12, 2010, Pages 760-767

  Rekowski, Margarete von Wantoch ^a   Giannis, Athanassios ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Histone acetyltransferases; Inhibitors

Indexed keywords

FATTY ACID; HISTONE ACETYLTRANSFERASE; TRANSCRIPTION FACTOR; TRICARBOXYLIC ACID;

ACETYLATION; AMINO ACID SEQUENCE; ENZYME ACTIVITY; GENE CONTROL; GLYCOGEN METABOLISM; GLYCOLYSIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; UREA CYCLE;

ACETYLATION; ANIMALS; CITRIC ACID CYCLE; DIABETES MELLITUS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GLYCOGEN; GLYCOLYSIS; HISTONE ACETYLTRANSFERASES; HISTONES; HIV INFECTIONS; HUMANS; NEOPLASMS; NEURODEGENERATIVE DISEASES; TRANSCRIPTION FACTORS;

EID: 78649894738     PISSN: 18749399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2010.05.006     Document Type: Review

References (82)

1. Khorasanizadeh S. The nucleosome: from genomic organization to genomic regulation. Cell 2004, 116:259-272.
2. Arents G., Burlingame R.W., Wang B.C., Love W.E., Moudrianakis E.N. The nucleosomal core histone octamer at 3.1 A resolution: a tripartite protein assembly and a left-handed superhelix. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:10148-10152.
3. Arents G., Moudrianakis E.N. Topography of the histone octamer surface: repeating structural motifs utilized in the docking of nucleosomal DNA. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:10489-10493.
4. Kornberg R.D., Lorch Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 1999, 98:285-294.
5. Luger K., Mader A.W., Richmond R.K., Sargent D.F., Richmond T.J. Crystal structure of the nucleosome core particle at 2.8Å resolution. Nature 1997, 389:251-260.
6. Allfrey V.G., Faulkner R., Mirsky A.E. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc. Natl. Acad. Sci. U. S. A. 1964, 61:786-794.
7. Spotswood H.T., Turner B.M. An increasingly complex code. J. Clin. Invest. 2002, 110:577-582.
8. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
9. Schreiber S.L., Bernstein B.E. Signaling network Model of chromatin. Cell 2002, 111:771-778.
10. Johnson J.A., Turner B.M. Histone deacetylases: complex transducers of nuclear signals. Semin. Cell Dev. Biol. 1999, 10:179-188.
11. Kurdistani S.K., Grunstein M. Histone acetylation and deacetylation in yeast. Nat. Rev. Mol. Cell Biol. 2003, 4:276-284.
12. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature 2000, 403:41-45.
13. Turner B.M. Histone acetylation and an epigenetic code. Bioessays 2000, 22:836-845.
14. Brownell J.E., Zhou J., Ranalli T., Kobayashi R., Edmondson D.G., Roth S.Y., Allis C.D. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 1996, 84:843-851.
15. Roth S.Y., Denu J.M., Allis C.D. Histone acetyltransferases. Annu. Rev. Biochem. 2001, 70:81-120.
16. Sterner D.E., Berger S.L. Acetylation of histones and transcription related factors. Microbiol. Mol. Biol. Rev. 2000, 64:435-459.
17. Mujtaba S., He Y., Zeng L., Farooq A., Carlson J.E., Ott M., Verdin E., Zhou M.-M. Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. Mol. Cell 2002, 9:575-586.
18. Biel M., Wascholowski V., Giannis A. Epigenetics-an epicenter of gene regulation: histones and histone-modifying enzymes. Angew. Chem. Int. Ed. 2005, 44:3186-3216.
19. Zhao S., Xu W., Jiang W., Yu W., Lin Y., Zhang T., Yao J., Zhou L., Zeng Y., Li H., Li Y., Shi J., An W., Hancock S.M., He F., Qin L., Chin J., Yang P., Chen X., Lei Q., Xiong Y., Guan K.-L. Regulation of cellular metabolism by protein lysine acetylation. Science 2010, 327:1000-1004.
20. Wang Q., Zhang Y., Yang C., Xiong H., Lin Y., Yao J., Li H., Xie L., Zhao W., Yao Y., Ning Z.-B., Zeng R., Xiong Y., Guan K.-L., Zhao S., Zhao G.-P. Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science 2010, 327:1004-1007.
21. Polevoda B., Sherman F. The diversity of acetylated proteins. Genome Biol. 2002, 3. reviews 0006.1.
22. Yang J.-X., Seto E. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 2007, 26:5310-5318.
23. Zhang Y., Li N., Caron C., Matthias G., Hess D., Khochbin S., Matthias P. HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J. 2003, 22:1168-1179.
24. Lau O.D., Kundu T.K., Soccio R.E., Alt-Si-Ali S., Khalil E.M., Vassilev A., Wolffe A.P., Nakatani Y., Reoder R.G., Cole P.A. HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Mol. Cell 2000, 5:589-595.
25. Giordano A., Avantaggiati M.L. p300 and CBP: partners for life and death. J. Cell. Physiol. 1999, 181:218-230.
26. Pfister S., Rea S., Taipale M., Mendrzyk F., Straub B., Ittrich C., Thuerigen O., Sinn H.P., Akhtar A., Lichter P. The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma. Int. J. Cancer 2008, 122:1207-1213.
27. Marmorstein R. Biochemical and structural characterization of recombinant histone acetyltransferase proteins. Meth. Enzymol. 2004, 376:106-119.
28. Tanner K.G., Trievel R.C., Kuo M.-H., Howards R.M., Berger S.L., Allis C.D., Marmorstein R., Denu J.M. Catalytic mechanism and function of invariant glutamic acid 173 from the histone acetyltransferase Gcn5 transcriptional coactivator. J. Biol. Chem. 1999, 274:18157-18160.
29. Lau O.D., Courtney A.D., Vassilev A., Marzilli L.A., Cotter R.J., Nakatani Y., Cole P.A. p300/CBP-associated factor histone acetyltransferase processing of a peptide substrate: kinetic analysis of the catalytic mechanism. J. Biol. Chem. 2000, 275:21953-21959.
30. Tanner K.G., Langer M.R., Denu J.M. Kinetic mechanism of human histone acetyltransferase P/CAF. Biochemistry 2000, 39:11961-11969.
31. Tanner K.G., Langer M.R., Kim Y., Denu J.M. Kinetic mechanism of the histone acetyltransferase Gcn5 from yeast. J. Biol. Chem. 2000, 275:22048-22055.
32. Trievel R.C., Rojas J.R., Sterner D.E., Venkataramani R.N., Wang L., Zhou J., Allis C.D., Berger S.L., Marmorstein R. Crystal structure and mechanism of histone acetylation of the yeast Gcn5 transcriptional coactivator. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:8931-8936.
33. Lin Y., Fletcher C.M., Zhou J., Allis C.D., Wagner G. Solution structure of the catalytic domain of Gcn5 histone acetyltransferase bound to coenzyme A. Nature 1999, 400:86-89.
34. Rojas J.R., Trievel R.C., Zhou J., Mo Y., Li X., Berger S.L., Allis C.D., Marmorstein R. Structure of Tetrahymena Gcn5 bound to coenzyme A and a histone H3 peptide. Nature 1999, 401:93-98.
35. Clements A., Rojas J.R., Trievel R.C., Wang L., Berger S.L., Marmorstein R. Crystal structure of the histone acetyltransferase domain of the human PCAF transcriptional regulator bound to coenzyme A. EMBO J. 1999, 18:3521-3532.
36. Clements A., Poux A.N., Lo W.-S., Pillus L., Berger S.L., Marmorstein R. Structural basis for histone and phosphohistone binding by the Gcn5 histone acetyltransferase. Mol. Cell 2003, 12:461-473.
37. Vetting M.W. Structure and functions of the GNAT superfamily of acetyltransferases. Arch. Biochem. Biophys. 2005, 433:212-226.
38. Richon V.M., Emiliani S., Verdin E., Webb Y., Breslow R., Rifkind R.A., Marks P.A. A class of hybrid polar inducers of transformed cell differentiation inhibits histonedeacetylases. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:3003.
39. Zheng Y., Thompson P.R., Cebrat M., Wang L., Devlin M.K., Alani R.M., Cole P.A. Selective HAT inhibitors as mechanistic tools for protein acetylation. Meth. Enzymol. 2004, 376:188-199.
40. Stimson L., Rowlands M.G., Newbatt Y.M., Smith N.F., Raynaud F.I., Rogers P., Bavetsias V., Gorsuch S., Jarman M., Bannister A., Kouzarides T., McDonald E., Workman P., Aherne G.W. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity. Mol. Cancer Ther. 2005, 4:1521-1532.
41. Mantelingu K., Reddy B.A., Swaminathan V., Kishore A.H., Siddappa N.B., Kumar G.V., Nagashankar G., Natesh N., Roy S., Sadhale P.P., Ranga U., Narayana C., Kundu T.K. Specific inhibition of p300-HAT alters global gene expression and represses HIV replication. Chem. Biol. 2007, 14:645-657.
42. Morimoto T., Sunagawa Y., Kawamura T., Takaya T., Wada H., Nagasawa A., Komeda M., Fujita M., Shimatsu A., Kita T., Hasegawa K. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J. Clin. Invest. 2008, 118:868-878.
43. Thompson P.R., Kurooka H., Nakatani Y., Cole P.A. Transcriptional coactivator protein p300. Kinetic characterization of its histone acetyltransferase activity. J. Biol. Chem. 2001, 276:33721-33729.
44. Poux A.N., Cebrat M., Kim C.M., Cole P.A., Marmorstein R. Structure of the Gcn5 histone acetyltransferase bound to a bisubstrate inhibitor. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:14065-14070.
45. Zheng Y., Balasubramanyam K., Cebrat M., Buck D., Guidez F., Zelent A., Alani R.M., Cole P.A. Synthesis and evaluation of a potent and selective cell permeable p300 histone acetyltransferase inhibitor. J. Am. Chem. Soc. 2005, 127:17182-17183.
46. Liu X., Wang L., Zhao K., Thompson P.R., Hwang Y., Marmorstein R., Cole P.A. The structural basis of protein acetylation by the p300/CBP transcriptional coactivator. Nature 2008, 451:846-850.
47. Cebrat M., Kim C.M., Thompson P.R., Daugherty M., Cole P.A. Synthesis and analysis of potential prodrugs of coenzyme A analogues for the inhibition of the histone acetyltransferase p300. Bioorg. Med. Chem. 2003, 11:3307-3313.
48. Wu J., Xie N., Wu Z., Zhang Y., Zheng Y.G. Bisubstrate Inhibitors of the MYST HATs Esa1 and Tip60. Bioorg. Med. Chem. 2009, 17:1381-1386.
49. Balsubramanyam K., Swaminathan V., Ranganathan A., Kundu T.K. Small molecule modulators of histone acetyltransferase p300. J. Biol. Chem. 2003, 278:19134-19140.
50. Sun Y.L., Jiang X.F., Chen S.J., Price B.D. Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation. FEBS Lett. 2006, 580:4353-4356.
51. Souto J.A., Conte M., Alvarez R., Nebbioso A., Carafa V., Altucci L., de Lera A.R. Synthesis of benzamides related to anacardic acid and their histone acetyltransferase (HAT) inhibitory activities. ChemMedChem 2008, 1435-1442.
52. Eliseeva E.D., Valkov V., Jung M., Jung M.O. Characterization of novel inhibitors of histone acetyltransferases. Mol. Cancer Ther. 2007, 6:2391-2398.
53. Sbardella G., Castellano S., Vicidomini C., Rotili D., Nebbioso A., Miceli M., Altuccic L., Mai A. Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases. Bioorg. Med. Chem. Lett. 2008, 18:2788-2792.
54. Biel M., Kretsovali N., Karatzali E., Papamatheakis J., Giannis A. Design, synthesis, and biological evaluation of a small-molecule inhibitor of the histone acetyltransferase Gcn5. Angew. Chem. 2004, 116:4065-4067. Angew. Chem. Int. Ed. 43 (2004) 3974-3976.
55. Hoffmann H.M.R., Rabe J. Synthese und biologische Aktivität von α-Methylen-γ-butyrolactonen. Angew. Chem. 1985, 97:96-112. Angew. Chem. Int. Ed. Engl. 24 (1985).
56. Kuhn A.N., van Santan M.A., Schwienhorst A., Urlaub H., Lührmann R. Stalling of spliceosome assembly at distinct stages by small-molecule inhibitors of protein acetylation and deacetylation. RNA 2009, 15:153-175.
57. Gorsuch S., Bavetsias V., Rowlands M.G., Aherne G.W., Workman P., Jarman M., McDonald E. Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs). Bioorg. Med. Chem. 2009, 17:467-474.
58. Mai A. The therapeutic uses of chromatin-modifying agents. Expert Opin. Ther. Targets 2007, 11:835-851.
59. Choi K.-C., Gu Jung M., Lee Y.-H., Yoon J.C., Kwon S.H., Kang H.-B., Kim M.-J., Cha J.-H., Kim Y.J., Jun W.J., Lee J.M., Yoon H.-G. Epigallocatechin-3-Gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res. 2009, 69:583-592.
60. Balasubramanyam K., Altaf M., Varier R.A. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J. Biol. Chem. 2004, 279:33716-33726.
61. Balasubramanyam K., Varier R.A., Altaf M. Curcumin, A novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/ nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J. Biol. Chem. 2004, 279:51163-51171.
62. Maheshwari R.K., et al. Multiple biological activities of curcumin: a short review. Life Sci. 2006, 78:2081-2087.
63. Kang J., et al. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. Biochem. Pharmacol. 2005, 69:1205-1213.
64. Tourkina E., et al. Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. Am. J. Respir. Cell Mol. Biol. 2004, 31:28-35.
65. Marcu M.G., Jung Y.J., Lee S., Chung E.J., Lee M.J., Trepel J., Neckers L. Curcumin is an inhibitor of p300 histone acetyltransferase. Med. Chem. 2006, 2:169-174.
66. Anand P., Thomas S.G., Kunnumakkara A.B., Sundaram C., Harikumar K.B., Sung B., Tharakan S.T., Misra K., Priyadarsini I.K., Rajasekharan K.N., Aggarwal B.B. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem. Pharmacol. 2008, 76:1590-1611.
67. Mishra S., Kapoor N., Mubarak Ali A., Pardhasaradhi B.V.V., Kumari A.L., Khar A., Misra K. Differential apoptotic and redox regulatory activities of curcumin and its derivatives. Free Radic. Biol. Med. 2005, 38:1353-1360.
68. Weber W.M., Hunsaker L.A., Abcouwer S.F., Deck L.M., Vander Jagt D.L. Anti-oxidant activities of curcumin and related enones. Bioorg. Med. Chem. 2005, 13:3811-3820.
69. Costi R., Di Santo R., Artico M., Miele G., Valentini P., Novellino E., Cereseto A. Cinnamoyl compounds as simple molecules that inhibit p300 histone acetyltransferase. J. Med. Chem. 2007, 50:1973-1977.
70. Balasubramanyam K., Altaf M., Varier R.A., Swaminathan V., Ravindran A., Sadhale P.P., Kundu T.K. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J. Biol. Chem. 2004, 279:33716-33726.
71. Marzio G., Giacca M. Chromatin control of HIV-1 gene expression. Genetica 1999, 106:125-130.
72. Gey C., Kyrylenko S., Hennig L., Nguyen L.H., Büttner A., Pham H.D., Giannis A. Phloroglucinol derivatives guttiferone G, aristoforin, and hyperforin: inhibitors of human sirtuins SIRT1 and SIRT2. Angew. Chem. 2007, 119:5311-5314.
73. Ciochina R., Grossman R.B. Polycyclic polyprenylated acylphloroglucinols. Chem. Rev. 2006, 106:3963-3986.
74. Arif M., Pradhan S.K., Thanuja G.R., Vedamurthy B.M., Agrawal S., Dasgupta D., Kundu T.K. Mechanism of p300 specific histone acetyltransferase inhibition by small molecules. J. Med. Chem. 2009, 52:267-277.
75. Zeng L., Zhou M.M. Bromodomain: an acetyl-lysine binding domain. FEBS Lett. 2002, 513:124-128.
76. Heery D.M., Fischer P.M. Pharmacological targeting of lysine acetyltransferases in human disease: a progress report. Drug Discov. Today 2007, 12:88-99.
77. Kaehlcke K., Dorr A., Hetzer-Egger C., Kiermer V., Henklein P., Schnoelzer M., Loret E., Cole P.A., Verdin E., Ott M. Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation. Mol. Cell 2003, 12:167-176.
78. Hudson B.P., Martinez-Yamout M.A., Dyson H.J., Wright P.E. Solution structure and acetyl-lysine binding activity of the Gcn5 bromodomain. J. Mol. Biol. 2000, 304:355-370.
79. Dhalluin C., Carlson J.E., Zeng L., He C., Aggarwal A.K., Zhou M.-M. Structure and ligand of a histone acetyltransferase bromodomain. Nature 1999, 399:491-496.
80. Mujtaba S., He Y., Zeng L., Yan Sh., Plotnikova O., Sachchidanand, Sanchez R., Zeleznik-Le N.J., Ronai Z., Zhou M.-M. Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mol. Cell 2004, 13:251-263.
81. Jacobson R.H., Ladurner A.G., King D.S., Tjian R. Structure and function of a human TAFII250 double bromodomain module. Science 2000, 288:1422-1425.
82. Zeng L., Li J., Muller M., Yan S., Mujtaba S., Pan C., Wang Z., Zhou M.-M. Selective small molecules blocking HIV-1 Tat and coactivator PCAF association. J. Am. Chem. Soc. 2005, 127:2376-2377.